Volcano legal win a best-case scenario, says Leerink

theflyonthewall.com

Leerink believes Volcano's (VOLC) legal win Friday against St. Jude Medical (STJ) presents a best-case scenario and removes a headline risk for the company. The firm reiterates an Outperform rating on shares of Volcano with a $32 price target.

View Comments (0)